Bausch Health Cos., Inc. (BHC)
6.325
+0.02
(+0.40%)
USD |
NYSE |
Aug 28, 16:00
6.325
0.00 (0.00%)
After-Hours: 20:00
Bausch Health Cos. Total Liabilities (Quarterly) : 25.60B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 25.60B |
| March 31, 2026 | 25.58B |
| December 31, 2025 | 25.99B |
| September 30, 2025 | 26.47B |
| June 30, 2025 | 27.12B |
| March 31, 2025 | 26.66B |
| December 31, 2024 | 26.84B |
| September 30, 2024 | 26.78B |
| June 30, 2024 | 26.72B |
| March 31, 2024 | 27.09B |
| December 31, 2023 | 27.43B |
| September 30, 2023 | 27.30B |
| June 30, 2023 | 25.23B |
| March 31, 2023 | 25.30B |
| December 31, 2022 | 25.43B |
| September 30, 2022 | 25.86B |
| June 30, 2022 | 27.92B |
| March 31, 2022 | 29.23B |
| December 31, 2021 | 29.24B |
| September 30, 2021 | 29.39B |
| June 30, 2021 | 30.65B |
| March 31, 2021 | 30.32B |
| December 31, 2020 | 30.59B |
| September 30, 2020 | 30.91B |
| June 30, 2020 | 30.85B |
| Date | Value |
|---|---|
| March 31, 2020 | 31.07B |
| December 31, 2019 | 32.73B |
| September 30, 2019 | 29.11B |
| June 30, 2019 | 29.67B |
| March 31, 2019 | 29.77B |
| December 31, 2018 | 29.68B |
| September 30, 2018 | 30.54B |
| June 30, 2018 | 30.89B |
| March 31, 2018 | 31.28B |
| December 31, 2017 | 31.55B |
| September 30, 2017 | 34.55B |
| June 30, 2017 | 37.70B |
| March 31, 2017 | 38.34B |
| December 31, 2016 | 40.27B |
| September 30, 2016 | 41.49B |
| June 30, 2016 | 42.26B |
| March 31, 2016 | 43.24B |
| December 31, 2015 | 42.93B |
| September 30, 2015 | 41.99B |
| June 30, 2015 | 41.78B |
| March 31, 2015 | 31.99B |
| December 31, 2014 | 20.90B |
| September 30, 2014 | 21.83B |
| June 30, 2014 | 22.53B |
| March 31, 2014 | 22.79B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | 2.242M |
| NervGen Pharma Corp. | 51.39M |
| Milestone Pharmaceuticals, Inc. | 163.41M |
| Clearmind Medicine, Inc. | 3.033M |
| Lexaria Bioscience Corp. | 0.4371M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 24.79B |
| Shareholders Equity (Quarterly) | -1.771B |
| Debt to Equity Ratio | -11.73 |
| Current Ratio | 1.435 |
| Net Debt Paydown Yield | 7.93% |